revealed that CAF could boost cholesterol and steroid biosynthesis levels in PCa cells by highly upregulating the expression of HMGCS2 and AKR1C3 to promote androgen receptor-targeted therapy resistance in PCa. This evidence concerns the gene HMGCS2 and posterior cortical atrophy.